Sign in
4

Changes in Ownership

Akebia Therapeutics, Inc. Filed Acc 0001209191-16-101851

SVP, General Counsel, Sec. acquired 22,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Hadas Nicole R. SVP, General Counsel, Sec. 2016-02-22 Grant or award +22,500 87,084 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Hadas Nicole R. SVP, General Counsel, Sec. 2016-02-22 Grant or award · Stock Option (Right to Buy) +34,300 34,300 D: show line 2 in the form
Loading xslF345X03/doc4.xml…